El-Toukhy Naglaa, Emam Sherin M
Department of Hepatology & Gastroenterology & Infectious diseases,Faculty of Medicine, Benha University, Benha, Egypt.
Department of Medical Microbiology & Immunology,Faculty of Medicine, Benha University, Benha, Egypt.
Egypt J Immunol. 2016 Jun;23(2):17-27.
Spontaneous bacterial peritonitis (SBP) is a severe complication in cirrhotics with ascites. Monocyte chemotactic protien-1 (MCP-1) is a chemotactic factor for monocytes/macrophages, and it activates lymphocytes and neutrophils during infection. This study aimed to evaluate the role of MPC-1 in the pathogenesis of SBP and assess its prognostic value and correlation to disease severity. The study included ninety patients with liver cirrhosis and ascites. Patients were divided into 2 groups: Group I including 45 ascetic patients with SBP (polymorph nuclear cell count (PMN) >= 250 cell/mm3 in ascitic fluid), and Group II including 45 ascetic patients without SBP. Assessment of the severity of liver cirrhosis was done using the modified Child-Pugh and model for end stage liver disease (MELD) scores. Ascetic fluid samples were subjected to total leucocytic count and differential, albumin, protein, glucose, and serum-ascetic albumin gradient analysis Ascetic fluid levels of (MCP-1was measured by ELISA. Higher level was detected in patients with SBP as compared to those without SBP. The number of polymorph nuclear cell count (PMN) >= 250 cell/mm3 in ascitic fluid) was used as gold standard for diagnosis of SBP. The diagnosis sensitivity and specificity of MCP level test were 86.7% and 95.4% respectively at cutoff of122.5ng/ml with accuracy 91%. MCP-1 level showed positive significant correlation with TLC, PMN leucocytes and MELD score. In conclusion, ascitic fluid MCP-1 level could be a reliable test for diagnosis of SBP, and could be used as a prognostic marker due to its positive correlation with the severity of liver disease.
自发性细菌性腹膜炎(SBP)是肝硬化腹水患者的一种严重并发症。单核细胞趋化蛋白-1(MCP-1)是单核细胞/巨噬细胞的趋化因子,在感染期间可激活淋巴细胞和中性粒细胞。本研究旨在评估MCP-1在SBP发病机制中的作用,评估其预后价值以及与疾病严重程度的相关性。该研究纳入了90例肝硬化腹水患者。患者分为两组:第一组包括45例患有SBP的腹水患者(腹水多形核细胞计数(PMN)≥250个细胞/mm³),第二组包括45例无SBP的腹水患者。使用改良的Child-Pugh评分和终末期肝病模型(MELD)评分评估肝硬化的严重程度。对腹水样本进行白细胞总数及分类、白蛋白、蛋白质、葡萄糖和血清-腹水白蛋白梯度分析。通过酶联免疫吸附测定法(ELISA)检测腹水中MCP-1的水平。与无SBP的患者相比,SBP患者的MCP-1水平更高。腹水多形核细胞计数(PMN)≥250个细胞/mm³被用作SBP诊断的金标准。当截断值为122.5ng/ml时,MCP水平检测的诊断敏感性和特异性分别为86.7%和95.4%,准确率为91%。MCP-1水平与白细胞总数、PMN白细胞和MELD评分呈显著正相关。总之,腹水MCP-1水平可能是诊断SBP的可靠检测指标,由于其与肝病严重程度呈正相关,故可作为预后标志物。